Tailored therapy for <i>Helicobacter pylori</i> eradication: A systematic review and meta-analysis.

Front Pharmacol · 2022 · PMC9495299 · PMID 36160444

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Overall, we found a nonsignificant trend toward fewer AEs among participants who received tailored therapy than among those who received empirical treatment (RR, 0.90 [95% CI, 0.80–1.01], I 2 = 35.7%; Figure 5 ) .

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.